The founder mutation MSH2*1906G→C is an important cause of hereditary nonpolyposis colorectal cancer in the Ashkenazi Jewish population

被引:106
作者
Foulkes, WD
Thiffault, I
Gruber, SB
Horwitz, M
Hamel, N
Lee, C
Shia, J
Markowitz, A
Figer, A
Friedman, E
Farber, D
Greenwood, CMT
Bonner, JD
Nafa, K
Walsh, T
Marcus, V
Tomsho, L
Gebert, J
Macrae, FA
Gaff, CL
Bressac-de Paillerets, B
Gregersen, PK
Weitzel, JN
Gordon, PH
MacNamara, E
King, MC
Hampel, H
de la Chapelle, A
Boyd, J
Offit, K
Rennert, G
Chong, G
Ellis, NA
机构
[1] McGill Univ, Sir Mortimer B Davis Jewish Gen Hosp, Dept Med, Montreal, PQ, Canada
[2] McGill Univ, Sir Mortimer B Davis Jewish Gen Hosp, Dept Oncol, Montreal, PQ, Canada
[3] McGill Univ, Sir Mortimer B Davis Jewish Gen Hosp, Dept Surg, Montreal, PQ, Canada
[4] McGill Univ, Sir Mortimer B Davis Jewish Gen Hosp, Dept Diagnost Med, Montreal, PQ, Canada
[5] McGill Univ, Ctr Hlth, Dept Med, Montreal, PQ, Canada
[6] McGill Univ, Ctr Hlth, Dept Human Genet, Montreal, PQ, Canada
[7] McGill Univ, Ctr Hlth, Dept Pathol, Montreal, PQ, Canada
[8] McGill Univ, Ctr Hlth, Dept Epidemiol, Montreal, PQ, Canada
[9] McGill Univ, Ctr Hlth, Dept Biostat, Montreal, PQ, Canada
[10] McGill Univ, Ctr Hlth, Inst Res, Montreal, PQ, Canada
[11] McGill Univ, Program Canc Genet, Dept Oncol, Montreal, PQ, Canada
[12] McGill Univ, Program Canc Genet, Dept Human Genet, Montreal, PQ, Canada
[13] Univ Michigan, Div Med & Mol Genet, Dept Internal Med, Ann Arbor, MI 48109 USA
[14] Univ Michigan, Div Med & Mol Genet, Dept Epidemiol, Ann Arbor, MI 48109 USA
[15] Univ Washington, Div Med Genet, Dept Med, Seattle, WA 98195 USA
[16] Mem Sloan Kettering Canc Ctr, Dept Med, New York, NY 10021 USA
[17] Mem Sloan Kettering Canc Ctr, Dept Pathol, New York, NY 10021 USA
[18] Mem Sloan Kettering Canc Ctr, Dept Surg, New York, NY 10021 USA
[19] Elias Sourasky Med Ctr, Gastrointestinal Tumor Serv, Tel Aviv, Israel
[20] Chaim Sheba Med Ctr, Susanne Levy Gertner Oncogenet Unit, IL-52621 Tel Hashomer, Israel
[21] Univ Heidelberg, Inst Pathol, Div Mol Pathol, D-6900 Heidelberg, Germany
[22] Royal Melbourne Hosp, Family Canc Clin, Melbourne, Vic, Australia
[23] Genet Hlth Serv Victoria, Melbourne, Vic, Australia
[24] Inst Gustave Roussy, Paris, France
[25] N Shore Long Isl Jewish Res Inst, Ctr Genom & Human Genet, Manhasset, NY USA
[26] City Hope Canc Ctr, Dept Canc Genet, Duarte, CA USA
[27] Ohio State Univ, Human Canc Genet Program, Columbus, OH 43210 USA
[28] Chalit Hlth Serv Canc Control Ctr, Haifa, Israel
关键词
D O I
10.1086/345075
中图分类号
Q3 [遗传学];
学科分类号
071007 ; 090102 ;
摘要
Hereditary nonpolyposis colorectal cancer (HNPCC) is caused by mutations in the mismatch-repair genes. We report here the identification and characterization of a founder mutation in MSH2 in the Ashkenazi Jewish population. We identified a nucleotide substitution, MSH2*1906G-->C, which results in a substitution of proline for alanine at codon 636 in the MSH2 protein. This allele was identified in 15 unrelated Ashkenazi Jewish families with HNPCC, most of which meet the Amsterdam criteria. Genotype analysis of 18 polymorphic loci within and flanking MSH2 suggested a single origin for the mutation. All colorectal cancers tested showed microsatellite instability and absence of MSH2 protein, by immunohistochemical analysis. In an analysis of a population-based incident series of 686 Ashkenazi Jews from Israel who have colorectal cancer, we identified 3 (0.44%) mutation carriers. Persons with a family history of colorectal or endometrial cancer were more likely to carry the mutation than were those without such a family history (P = .042), and those with colorectal cancer who carried the mutation were, on average, younger than affected individuals who did not carry it (P = .033). The mutation was not detected in either 566 unaffected Ashkenazi Jews from Israel or 1,022 control individuals from New York. In hospital-based series, the 1906C allele was identified in 5/463 Ashkenazi Jews with colorectal cancer, in 2/197 with endometrial cancer, and in 0/83 with ovarian cancer. When families identified by family history and in case series are included, 25 apparently unrelated Ashkenazi Jewish families have been found to harbor this mutation. Although this pathogenic mutation is not frequent in the Ashkenazi Jewish population (accounting for 2%-3% of colorectal cancer in those whose age at diagnosis is <60 years), it is highly penetrant and accounts for approximately one-third of HNPCC in Ashkenazi Jewish families that fulfill the Amsterdam criteria.
引用
收藏
页码:1395 / 1412
页数:18
相关论文
共 28 条
  • [1] Incidence of hereditary nonpolyposis colorectal cancer and the feasibility of molecular screening for the disease
    Aaltonen, LA
    Salovaara, R
    Kristo, P
    Canzian, F
    Hemminki, A
    Peltomäki, P
    Chadwick, RB
    Kääriäinen, H
    Eskelinen, M
    Järvinen, H
    Mecklin, JP
    de la Chapelle, A
    Percesepe, A
    Ahtola, H
    Härkönen, N
    Julkunen, R
    Kangas, E
    Ojala, S
    Tulikoura, J
    ValKamo, E
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 1998, 338 (21) : 1481 - 1487
  • [2] AndreuttiZaugg C, 1997, CANCER RES, V57, P3288
  • [3] Boland CR, 1998, CANCER RES, V58, P5248
  • [4] Clinicopathologic features of BRCA-linked and sporadic ovarian cancer
    Boyd, J
    Sonoda, Y
    Federici, MG
    Bogomolniy, F
    Rhei, E
    Maresco, DL
    Saigo, PE
    Almadrones, LA
    Barakat, RR
    Brown, CL
    Chi, DS
    Curtin, JP
    Poynor, EA
    Hoskins, WJ
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2000, 283 (17): : 2260 - 2265
  • [5] A novel germline 1.8-kb deletion of hMLH1 mimicking alternative splicing:: a founder mutation in the Chinese population
    Chan, TL
    Yuen, ST
    Ho, JWC
    Chan, ASY
    Kwan, KD
    Chung, LP
    Lam, PWY
    Tse, CW
    Leung, SY
    [J]. ONCOGENE, 2001, 20 (23) : 2976 - 2981
  • [6] Recurrent germline mutation in MSH2 arises frequently de novo
    Desai, DC
    Lockman, JC
    Chadwick, RB
    Gao, X
    Percesepe, A
    Evans, DGR
    Miyaki, M
    Yuen, ST
    Radice, P
    Maher, ER
    Wright, FA
    de la Chapelle, A
    [J]. JOURNAL OF MEDICAL GENETICS, 2000, 37 (09) : 646 - 652
  • [7] Fleiss JL, 1981, STAT METHODS RATES P
  • [8] GREEN RC, 1994, AM J HUM GENET, V54, P1067
  • [9] Complex genetic predisposition to cancer in an extended HNPCC family with an ancestral hMLH1 mutation
    Hutter, P
    Couturier, A
    Scott, RJ
    Alday, P
    DelozierBlanchet, C
    Cachat, F
    Antonarakis, SE
    Joris, F
    Gaudin, M
    DAmato, L
    Buerstedde, JM
    [J]. JOURNAL OF MEDICAL GENETICS, 1996, 33 (08) : 636 - 640
  • [10] A high-resolution recombination map of the human genome
    Kong, A
    Gudbjartsson, DF
    Sainz, J
    Jonsdottir, GM
    Gudjonsson, SA
    Richardsson, B
    Sigurdardottir, S
    Barnard, J
    Hallbeck, B
    Masson, G
    Shlien, A
    Palsson, ST
    Frigge, ML
    Thorgeirsson, TE
    Gulcher, JR
    Stefansson, K
    [J]. NATURE GENETICS, 2002, 31 (03) : 241 - 247